Scholar Rock Holding SRRK
NASDAQ SRRK
$55.13 -0.81 (-1.45%)
As of: Sep 4, 2026 · 1:41 PM EDT

Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Amortizatization of Intangibles of $169000.0 for Q1 2026, down 91.13% year-over-year from $1.9 million in Q1 2025, and down 14.65% quarter-over-quarter from $198000.0 in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends

Scholar Rock Holding's Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $169000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 91.13% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $2.3 million (down 57.31% YoY), while the FY2025 annual figure was $4.0 million, down 24.61% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $169000.0, down from $198000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $1.9 million in Q1 2024, with the low at -$152000.0 in Q2 2022.
  • The 5-year median for Amortizatization of Intangibles is $1.3 million (2024), against an average of $1.0 million.
  • The sharpest annual moves came in 2022 and 2026: Amortizatization of Intangibles jumped 1598.18% in 2022, then plunged 91.13% in 2026.
  • Scholar Rock Holding's Amortizatization of Intangibles stood at $1.6 million in 2022, then rose by 9.41% to $1.8 million in 2023, then slipped by 25.35% to $1.3 million in 2024, then sank by 85.29% to $198000.0 in 2025, then retreated by 14.65% to $169000.0 in 2026.
  • Business Quant data shows SRRK's Amortizatization of Intangibles at $169000.0 in Q1 2026, $198000.0 in Q4 2025, and $495000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn -
5 Revolution Medicines 44.08 Bn 44.08 Bn - 4.33 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 678,000.00
10 Scholar Rock Holding 7.20 Bn 7.20 Bn - 1.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Mn
Mar 31, 2026 1.54 Mn
Dec 31, 2025 1.39 Mn
Sep 30, 2025 581,000.00
Jun 30, 2025 1.39 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 1.26 Mn
Sep 30, 2024 798,000.00
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 1.58 Mn
Sep 30, 2023 1.89 Mn
Jun 30, 2023 1.85 Mn
Mar 31, 2023 1.81 Mn
Dec 31, 2022 1.78 Mn
Sep 30, 2022 1.74 Mn
Jun 30, 2022 1.71 Mn
Mar 31, 2022 1.68 Mn
Dec 31, 2021 1.64 Mn
Sep 30, 2021 1.65 Mn